Video above: FDA votes to authorize more COVID-19 boosters, mix-and-matching doses in some casesA booster dose of the Pfizer/BioNTech coronavirus vaccine was found to have a high efficacy — 95.6% — ...

The European Union reached a deal with Pfizer and BioNTech for 300 million additional doses of their COVID-19 vaccine, the ...

Systematic review finds lifelong immunity from a single yellow fever vaccine, with rare cases of breakthrough infections. Study: Yellow fever breakthrough infections after yellow fever vaccination: a ...

A Pfizer-BioNTech Covid-19 booster shot appears to provide strong protection against the omicron variant, while the initial two-dose vaccine may be insufficient to prevent infection, the companies ...

EU chief executive Ursula von der Leyen vigorously defended the European Commission's record on vaccines on Tuesday and ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. SAN DIEGO — Patients with primary systemic vasculitis ...

Two pharmaceutical corporations announced they are working on a revolutionary breakthrough that could be more acclaimed than pockets on a sundress. Not since one of the ancestors combined corn and ...

Moderna announced on Wednesday it has completed its submission to the US Food and Drug Administration for full approval of its COVID-19 vaccine for people age 18 and older, and Pfizer and BioNTech ...

Vaccine makers are preparing for a next possible phase of the Covid-19 vaccine rollout: booster doses. The US Food and Drug Administration on Thursday authorized third doses of both the ...